Statistics for Evaluating the extent of reusability of CYP2C19 genotype data among patients genotyped for antiplatelet therapy selection
Total visits
| views | |
|---|---|
| Evaluating the extent of reusability of CYP2C19 genotype data among patients genotyped for antiplatelet therapy selection | 69 |
Total visits per month
| views | |
|---|---|
| August 2024 | 0 |
| September 2024 | 0 |
| October 2024 | 0 |
| November 2024 | 0 |
| December 2024 | 0 |
| January 2025 | 0 |
| February 2025 | 0 |
File Visits
| views | |
|---|---|
| Beitelshees2020Evaluating-NIHAAM.pdf | 44 |
| java.util.UUID:83eb28fe-2123-4c32-9ce9-af265a3f07bb | 12 |
| java.util.UUID:61fe9ef1-631a-49fe-a67d-feade171dfdd | 6 |
| java.util.UUID:ed25a7fa-f423-440f-8a7e-3cec78a5f740 | 2 |
Top country views
| views | |
|---|---|
| United States | 61 |
| Canada | 1 |
| Malaysia | 1 |
Top city views
| views | |
|---|---|
| Wilmington | 42 |
| Fairfield | 3 |
| White Plains | 3 |
| Houston | 2 |
| Ann Arbor | 1 |
| Cambridge | 1 |
| Kuala Lumpur | 1 |
| Mount Laurel | 1 |
| Washington | 1 |
| Winnipeg | 1 |